World Investment Advisors Decreases Stake in Docusign Inc. $DOCU

World Investment Advisors lowered its stake in Docusign Inc. (NASDAQ:DOCU) by 20.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,570 shares of the company’s stock after selling 911 shares during the period. World Investment Advisors’ holdings in Docusign were worth $278,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in DOCU. Wellington Management Group LLP raised its holdings in shares of Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock worth $148,714,000 after buying an additional 1,440,269 shares during the last quarter. Duquesne Family Office LLC acquired a new stake in Docusign during the 1st quarter valued at approximately $87,477,000. Pacer Advisors Inc. raised its holdings in shares of Docusign by 809.6% during the first quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company’s stock worth $95,017,000 after purchasing an additional 1,038,962 shares during the last quarter. Nuveen LLC purchased a new position in shares of Docusign during the first quarter worth $50,459,000. Finally, Victory Capital Management Inc. raised its holdings in shares of Docusign by 251.0% during the first quarter. Victory Capital Management Inc. now owns 734,588 shares of the company’s stock worth $59,795,000 after purchasing an additional 525,294 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Docusign Stock Performance

Shares of Docusign stock opened at $70.81 on Wednesday. The firm has a 50-day simple moving average of $75.11 and a two-hundred day simple moving average of $77.68. The company has a market cap of $14.24 billion, a P/E ratio of 53.24, a price-to-earnings-growth ratio of 3.63 and a beta of 1.01. Docusign Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $107.86.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.08. The company had revenue of $800.64 million during the quarter, compared to analysts’ expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities research analysts forecast that Docusign Inc. will post 1.17 EPS for the current year.

Insider Buying and Selling at Docusign

In other news, CFO Blake Jeffrey Grayson sold 6,500 shares of the business’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total transaction of $462,800.00. Following the completion of the sale, the chief financial officer owned 105,660 shares of the company’s stock, valued at $7,522,992. The trade was a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Robert Chatwani sold 13,817 shares of the business’s stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total transaction of $1,148,192.70. Following the sale, the insider directly owned 71,162 shares of the company’s stock, valued at $5,913,562.20. This represents a 16.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 102,533 shares of company stock valued at $7,709,933. Corporate insiders own 1.66% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on DOCU. Royal Bank Of Canada raised their target price on shares of Docusign from $90.00 to $95.00 and gave the stock a “sector perform” rating in a report on Friday, September 5th. Argus reissued a “hold” rating on shares of Docusign in a report on Monday, September 8th. Evercore ISI raised their target price on shares of Docusign from $90.00 to $92.00 and gave the stock an “in-line” rating in a report on Friday, September 5th. Piper Sandler raised their target price on shares of Docusign from $85.00 to $90.00 and gave the stock a “neutral” rating in a report on Friday, September 5th. Finally, UBS Group set a $95.00 target price on shares of Docusign in a report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fifteen have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $94.14.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.